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Abstract 
Background: The Finnish dairy herd recording system maintains production and health records of cows and herds. 
Veterinarians and farmers register veterinary treatments in the system. Milk samples for microbiological analysis are 
routinely taken from mastitic cows. The laboratory of the largest dairy company in Finland, Valio Ltd., analyzes most 
samples using real‑time PCR. This study addressed pathogen‑specific microbiological data and treatment and cull‑
ing records, in combination with cow and herd characteristics, from the Finnish dairy herd recording system during 
2010–2012.
Results: The data derived from 240,067 quarter milk samples from 93,529 dairy cows with mastitis; 238,235 cows 
from the same herds served as the control group. No target pathogen DNA was detected in 12% of the samples. 
In 49% of the positive samples, only one target species and in 19%, two species with one dominant species were 
present. The most common species in the samples with a single species only were coagulase‑negative staphylo‑
cocci (CNS) (43%), followed by Staphylococcus aureus (21%), Streptococcus uberis (9%), Streptococcus dysgalactiae (8%), 
Corynebacterium bovis (7%), and Escherichia coli (5%). On average, 36% of the study cows and 6% of the control cows 
had recorded mastitis treatments during lactation. The corresponding proportions were 16 and 6% at drying‑off. For 
more than 75% of the treatments during lactation, diagnosis was acute clinical mastitis. In the milk samples from cows 
with a recorded mastitis treatment during lactation, CNS and S. aureus were most common, followed by streptococci. 
Altogether, 48% of the cows were culled during the study. Mastitis was reported as the most common reason to cull; 
49% of study cows and 18% of control cows were culled because of mastitis. Culling was most likely if S. aureus was 
detected in the milk sample submitted during the culling year.
Conclusions: The PCR test has proven to be an applicable method also for large‑scale use in bacterial diagnostics. In 
the present study, microbiological diagnosis was unequivocal in the great majority of samples where a single species 
or two species with one dominating were detected. Coagulase‑negative staphylococci and S. aureus were the most 
common species. S. aureus was also the most common pathogen among the culled cows, which emphasizes the 
importance of preventive measures.
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Background
During recent decades, considerable structural changes 
have occurred in the dairy industry in many countries. 
In Finland, the total number of dairy farms has decreased 
substantially but average herd size and numbers of farms 
with automatic milking systems (AMS) have increased 
[1–3]. With increasing herd size, good management 
practices and care of the cows become ever more impor-
tant [4, 5]. Despite decades of mastitis control programs 
in countries with an intensive dairy industry, mastitis 
continues to be the most common and economically 
important disease of dairy cows. It considerably affects 
milk production, animal welfare, and food safety [6–8]. 
Today’s consumers make increasing demands for ade-
quate animal welfare as well as food quality and safety, 
which also must be taken into account on modern dairy 
farms [9].
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Mastitis results from intramammary infection (IMI), 
mostly caused by various bacterial species. Knowledge 
on the bacteriological etiology of IMI is important for 
efficient mastitis control and treatment [10, 11]. Distri-
bution of the pathogens causing IMI varies among coun-
tries and herds. The most common causes of IMI are the 
major pathogens Escherichia coli, Staphylococcus aureus, 
and environmental streptococci, and the minor pathogens 
coagulase-negative staphylococci (CNS) [12–15]. Previ-
ous studies on the microbiological etiology of mastitis 
or IMI were mainly based on sampling selected herds in 
different countries. In Finland, national surveys with a 
random sample from all Finnish dairy herds were pub-
lished [16]. In a previous Finnish study, Koivula et al. [17] 
used a smaller, culture-based bacteriological database of 
similar type as in this study. Some studies investigated 
the relationship between herd factors, such as general 
management, milking technique or production type, and 
distributions of mastitis-causing bacterial species in the 
herds [15, 18–20]. To our knowledge, studies combining 
pathogen-specific bacteriological mastitis data, treatment 
and culling records, and cow and herd characteristics 
from large national databases have not been carried out.
The Finnish dairy herd recording system has long tradi-
tions: it began in 1898 [21]. In 2015, the recording system 
covered 74% of dairy herds and 81% of dairy cows [22]. 
In herds belonging to this system, production records, 
including milk yield, milk protein content, milk fat con-
tent and milk somatic cell count (SCC), are recorded for 
every cow. The national health monitoring of dairy herds, 
constituted during the early 1980s, keeps health records 
for every Finnish cow. Veterinarians and farmers register 
all veterinary treatments per cow or herd in this system. 
The Nordic dairy herd health recording system is glob-
ally unique. In many countries, mastitis treatments are 
not recorded or are recorded at herd level only, or in con-
nection with a specific health project. Unfortunately, the 
completeness of the records for clinical mastitis in Finland, 
according to a study carried out in 2008, was only 56%, 
which was lower than in the other Nordic countries [23].
In Finland, milk samples for bacteriology are routinely 
taken in most cases of mastitis [24]. The laboratory of the 
largest dairy company in Finland, Valio Ltd., analyzes the 
majority of these samples: 78% of Finnish dairy producers 
send milk samples to this laboratory (Personal communi-
cation Kristiina Sarjokari, Valio Ltd., 2016). Since 2010, 
a multiplex real-time polymerase chain reaction (PCR) 
assay has been used for the microbiological analyses.
Our first aim was to use a large microbiological data-
base of quarter milk samples from mastitic dairy cows 
to study the bacteriological etiology of mastitis in Fin-
land. Our second aim was to study treatment and cull-
ing records for the cows in the study herds collected from 
the databases of the Finnish dairy herd recording system. 
Detailed analysis of the relationships between pathogen-
specific IMI and different cow- and herd-specific factors 
are presented in Taponen et  al. [25]. The present study 
provides information about a PCR assay used for routine 
microbiological diagnostics of mastitic milk samples.
Methods
Microbiological data
Microbiological diagnoses of quarter milk samples from 
mastitic cows analyzed at the laboratory of Valio Ltd. dur-
ing 2010, 2011 and 2012 were received from the database 
of Valio Ltd. For microbiological analyses, PathoProof™ 
Mastitis PCR Complete-12 assay (Thermo Fisher Scien-
tific, Waltham, MA, USA) was used, which contained 
oligonucleotides for the staphylococcal β-lactamase 
gene (blaZ) and for the following microbial species or 
groups of species: Corynebacterium bovis, Enterococ-
cus spp., including Enterococcus faecalis and Enterococ-
cus faecium, E. coli, Klebsiella oxytoca and Klebsiella 
pneumoniae, Serratia marcescens, Staphylococcus spp., 
including all relevant CNS, S. aureus, Streptococcus aga-
lactiae, Streptococcus dysgalactiae, Streptococcus uberis, 
and Trueperella pyogenes and Peptoniphilus indolicus. 
In March 2012, the test kit was changed to PathoProof™ 
Mastitis PCR Complete-16 assay, which also includes 
Mycoplasma (M.) spp., Mycobacterium bovis, Prototheca 
spp., and yeasts.
The reason for milk sampling was evidence of clinical 
or subclinical mastitis (elevated milk SCC) in the quar-
ter. Milk sample was taken by herd staff or a visiting vet-
erinarian using an aseptic technique [26]. In this study, 
a cow with a quarter milk sample with DNA of at least 
one target pathogen species in the PCR assay was consid-
ered to have IMI. These cows comprise the study group. 
Only samples with microbial DNA of one microbial spe-
cies alone were included in calculation of the proportions 
of different pathogens. The control group comprised all 
other cows from the same herds: those for which no milk 
samples were sent for microbiological analysis to the lab-
oratory of Valio Ltd.
Bacteriological data for 2010–2012 consisted of micro-
biological results from 240,067 quarter milk samples 
(Table 1). Samples were taken from 93,529 dairy cows in 
4725 dairy herds. The control group consisted of 238,235 
cows from the same dairy herds. In the analyses carried 
out on an annual basis, the same cow may appear several 
times.
Milk and health recording data
Milk and health recording data of the cows were received 
from the databases of the Finnish dairy herd recording 
system, and the Finnish cattle health monitoring system.
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The data include information on individual cows for 
breed, age, parity, annual milk, fat and protein yield, 
results of test milking six to twenty-four times a year, 
the number of feeding days, date of diagnosis and treat-
ment for mastitis (clinical, subclinical) or dry cow ther-
apy (DCT), and date and reason for culling. The data also 
provide herd-specific information, such as that for milk-
ing and housing system and production type (organic vs. 
conventional) for 93% of the cows in the dataset.
In Finland and other Nordic countries, only veterinar-
ians are permitted to prescribe antimicrobials for use in 
animals. According to Finnish legislation, veterinarians 
record treatment of a cow after administering products 
with a withdrawal period, such as antimicrobials. Treat-
ment records are regularly submitted to the central cat-
tle health database. In subclinical or mild clinical mastitis, 
herd staff often take a milk sample and send it for microbi-
ological analysis and contact their veterinarian after receiv-
ing the microbiological result. Mastitis treatment in such 
cases may be prescribed without the veterinarian visiting 
the farm, and the herd staff should record the treatment for 
that cow. Veterinary-supervised cases are recorded using 
four different codes for mastitis during lactation: acute 
clinical, subclinical, chronic, and unspecified mastitis, and 
one code for DCT [27]. Herd staff use three additional 
codes to record treatment of mastitis: mastitis during lac-
tation, DCT for mastitis, and DCT for prevention. Finnish 
legislation concerning antimicrobial treatments of produc-
tion animals changed after the onset of this study. Dairy 
farmers now have limited access to antimicrobials to treat 
some predefined diseases like subclinical mastitis, on cer-
tain conditions. These herds have to belong to herd health 
recording system and have regular visits of a supervising 
veterinarian. Microbiological results of milk samples shall 
be available before treatment of mastitis.
The data were organized and analyzed using SAS 9.4 
(SAS Institute Inc., Cary, NC, USA) and SPSS 22 (IBM 
SPSS Statistics, Armonk, NY, USA) software. Differences 
in the treatment records for mastitis between the study 
group and the control group were tested using a Chi 
square test.
Results
Characteristics of cows and herds
In our data, 61.9% of cows were Nordic Red (NR), also 
known as Finnish Ayrshire, 36.6% Holstein (HOL), and 
1.8% Finncattle, Jersey, or different crossbreds. The mean 
parity was 2.4 in NR and 2.2 in HOL cows (range 1–15). 
The proportions of parities 1, 2, 3 and ≥4 were 33.8, 26.5, 
18.4, and 21.3%, respectively. The average annual milk 
production of the cows was 8598 kg per cow, 8323 kg for 
NR and 9154 kg for HOL cows.
Most herds were in conventional production systems 
and only 1.9% of the cows were on organic farms. 1.6% 
of both NR and HOL cows were in organic production, 
but for Finncattle the proportion was 7.7%. The average 
herd size was 44.7, 46.5, and 48.0 in 2010, 2011, and 2012, 
respectively. The minimum number of cows in a herd was 
three for all years, but the maximum number increased 
from 444 in 2010 to 498 in 2012. The proportions of free-
stalls and AMS increased during the study period. In the 
entire period, 51.8% of the cows were housed in tie-stall 
barns, 46.6% in different types of free-stall barns, and 
1.6% in barns with different mixed systems. In total, 52.0% 
of the cows were milked with a pipeline milking system in 
tie stalls, 30.4% in a milking parlor, 17.0% with AMS, and 
0.6% with a bucket milking machine in tie stalls.
Microbiological results of the milk samples
DNA of some target pathogen species or group of spe-
cies was detected in 87.6% of the quarter milk samples. 
12.4% of the samples were negative, i.e. did not contain 
DNA of any target species. In 49% of the samples, DNA 
of only one target species or group of species, and in 
25.2% two species or group of species, were detected. In 
samples with DNA of two bacterial species, a dominant 
Table 1 Number of  quarter milk samples, cows sampled (study group) and  control cows (no milk samples submitted) 
in 2010, 2011 and 2012
2010 2011 2012 Total number 
of samples
Samples 64,630 84,413 91,024 240,067
Samples with one target pathogen 31,731 44,037 41,743 117,511
Total number of cows Total number 
of individual cows
Cows in the study group 32,723 41,949 45,582 120,254 93,529
Cows in the control group 177,409 177,205 180,427 535,041 238,235
Total number of cows 210,132 219,154 226,009 655,295 331,764
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species (>90% of the total target DNA in the sample) was 
present in 66.2% of the samples. In 13.4% of all samples, 
DNA of more than two bacterial species was found. In 
these samples, the number of target species or group of 
species detected in the sample was as follows: 3 in 9.2%, 
4 in 2.9%, 5 in 0.9%, 6 in 0.3%, 7 in 0.07%, and 8 or 9 in 
less than 0.02%. One milk sample contained DNA from 
10 target species or group of species.
The most common bacteria detected in milk samples 
were CNS and S. aureus. Results for milk samples with 
DNA of only one microbial species or group of species 
are shown in Table 2. Mean cycle threshold (Ct) values, 
reflecting the amount of pathogen DNA in the sample, 
ranged between 21.9 and 33.1 (Table 2). The staphylococ-
cal BlaZ gene was found in 27.5% of samples with DNA 
of CNS and in 26.9% of samples with DNA of S. aureus.
In milk samples with two bacterial species or groups 
of species detected, with one dominant species, the most 
common dominant species were CNS (40.2%), Str. dys-
galactiae (16.7%), S. aureus (14.4%), Streptococcus uberis 
(10.0%) and T. pyogenes/P. indolicus (5.3%). The most 
common species present in the sample together with the 
previously listed dominant species were C. bovis (29.6%), 
CNS (18.4%), yeasts (11.6%), T. pyogenes/P. indolicus 
(10.9%) and S. aureus (7.7%).
Mastitis treatments
In total, 53,993 cows in the study group and 63,843 
cows in the control group received treatment for mas-
titis, received DCT, or received both. The proportion of 
cows in the study and control groups treated for clinical 
or subclinical mastitis, or with DCT, and the number of 
treatments per cow are presented in Table  3. The pro-
portions of cows treated during lactation and with DCT 
were significantly higher in the study group than in the 
control group (p < 0.001). Quarter milk samples for bac-
teriology were submitted to the laboratory on average 
from 56.4% of the cows with a recorded treatment during 
lactation during the same year; this percentage increased 
during the study period from 47.4 to 64.4%.
Proportions of different mastitis diagnoses of the study 
group cows among the veterinary-supervised mastitis 
treatments reported in the health recording system in 
2012 were as follows: acute clinical mastitis 75.2%, sub-
clinical mastitis 9.6%, chronic mastitis 2.0%, unspecified 
mastitis 7.4%, and mastitis noted by herd staff 5.7% (mas-
titis during lactation). The respective figures in the con-
trol group were 77.7, 8.7, 2.1, 7.4 and 4.1%. Cows in the 
study group and treated after diagnosis of acute clinical 
mastitis, had most often the following species or group 
of species in their milk sample during the treatment year: 
CNS (22.6% of the cows), S. aureus (22.5%), Str. uberis 
(9.99%), Str. dysgalactiae (9.02%), E. coli (5.5%), and C. 
bovis (3.6%). For cows in the study group and treated for 
subclinical mastitis during the year, the order of the spe-
cies was the same, with the exception of E. coli and C. 
bovis: The proportion of cows having C. bovis was higher 
than that of E. coli. The share of cows having CNS was 
31.5%.
Culling of cows
Altogether 48.1% of the individual cows were culled dur-
ing the 3-year study period. The reason for culling was 
reported for 88.5% of those cows. Among the reported 
reasons, the main causes were mastitis (23.6%) and poor 
fertility (19.0%). In the study group, mastitis was reported 
as the reason for culling for 49.1% of the culled cows 
for which the culling reason was reported. In the con-
trol group, the respective proportion was 18.2%. Table 4 
shows the numbers and proportions of cows culled due 
to mastitis. The pathogens detected most often in the 
milk samples of the culled cows are also presented in the 
table.
Discussion
This study reports bacteriological results from bovine 
intramammary infections using information from more 
than 240,000 quarter milk samples analyzed with real-
time PCR. Finland is to our knowledge the only country 
Table 2 Number and proportion of samples with DNA of a 
target bacterial species or group of species detected alone 
in  117,511 quarter milk samples analyzed in  the labora-
tory of Valio Ltd. in Finland during 2010–2012 using Path-
oProofTM Mastitis PCR Assay, and the mean cycle thresh-
old (Ct) values
a Ct value reflects the amount of pathogen DNA in the sample: the lower Ct 
value, the more DNA
Pathogen N % Mean  
Ct  valuea
CNS 50,836 43.3 31.5
 Staphylococcus aureus 24,754 21.1 28.0
 Streptococcus uberis 10,572 9.0 26.6
 Streptococcus dysgalactiae 9292 7.9 27.0
 Corynebacterium bovis 8510 7.2 31.9
 Escherichia coli 5562 4.7 29.3
 Trueperella pyogenes/Peptoniphilus 
indolicus
2921 2.5 26.0
Yeasts 1812 1.5 31.3
 Enterococcus spp. 1722 1.5 30.7
 Klebsiella spp. 836 0.7 28.9
 Streptococcus agalactiae 501 0.4 25.6
 Serratia marcescens 149 0.1 33.1
 Prototheca sp. 34 0 32.7
 Mycoplasma spp. 7 0 21.9
 Mycoplasma bovis 3 0 27.1
Total 117,511 100
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where PCR testing has largely replaced conventional 
culturing in routine microbiological diagnostics of quar-
ter milk samples from mastitic cows [28, 29]. The PCR 
method used here identifies a wider range of target path-
ogens than commonly revealed by routine conventional 
culturing [24]. The uniform diagnostic method used and 
the large numbers of samples allowed us to make confi-
dent inferences on the microbiological etiology of masti-
tis in Finland.
The majority of the milk samples contained DNA of 
some target species or group of species. The proportion 
of negative target DNA samples, 12.4%, was lower than 
the proportion of “no growth” samples in studies using 
conventional bacteriology, which generally has ranged 
from 20 to 40% [13, 15, 17, 29]. This is at least partly 
explained by the capacity of the PCR method to detect 
also DNA of growth-inhibited or dead microbes [30]. The 
samples with DNA of some target species were largely 
easy to interpret because in 49.0% of the samples DNA of 
only one target species or group of species was detected. 
This agrees with previous reports where the same PCR 
test was used with smaller materials [24, 28]. In samples 
with DNA of two bacterial species (25.2%), a dominant 
species, being the likely causal agent of IMI, was found 
in 66.2% of the samples. Thus, in 75% of all samples, the 
causal pathogen could be identified and the result was 
unequivocal. These results can be considered diagnosti-
cally valid [24]. In 13.4% of the samples, DNA of more 
Table 3 Proportion of cows in the study group and control group treated during lactation or at drying-off (dry cow ther-
apy) or both. Number of treatments per cow during the study year is also shown
Significance of difference: a, b, c, d, e, f, p < 0.001
Year Cows treated during lactation Cows treated at drying-off Cows treated both during  
lactation and at drying-off
Cows,  % Treatments per cow Cows, % Cows, % Treatments per cow
Study group
 2010 31.0a 1.31 9.4c 6.8e 2.48
 2011 29.4a 1.28 9.6c 6.6e 2.45
 2012 27.7a 1.27 9.2c 5.8e 2.40
 Average 29.3 1.29 9.4 6.4 2.44
 Total number of treated cows 35,074 11,287 7632
Control group
 2010 6.7b 1.23 5.2d 1.0f 2.35
 2011 5.4b 1.21 5.1d 0.7f 2.32
 2012 4.1b 1.19 4.6d 0.6f 2.31
 Average 5.4 1.21 5.0 0.8 2.33
 Total number of treated cows 28,976 30,762 4105
Table 4 Number and  proportion of  the cows culled with  mastitis as  the reported culling reason in  the study group 
and  the control group, and  the most common pathogens detected alone in  the milk samples of  the cows in  the study 
group during the same year
a Proportion of cows from the total number of cows culled and culling reason reported in study group and in control group, respectively
b Proportion of cows having the respective pathogen in their milk sample from the total number of culled cows in study group
2010 2011 2012
Number of culled cows % Number of culled cows % Number of culled cows %
Study group 3048 50.1a 4461 49.6a 4599 47.9a
 CNS 581 19.1b 949 21.3b 866 18.8b
  Staphylococcus aureus 888 29.1b 1383 31.0b 1239 26.9b
  Streptococcus uberis 210 6.9b 336 7.5b 294 6.4b
  Streptococcus dysgalactiae 168 5.5b 303 6.8b 221 4.8b
  Corynebacterium bovis 143 4.7b 225 5.0b 197 4.3b
  Escherichia coli 148 4.9b 238 5.3b 222 4.8b
Control group 7825 19.9a 6953 18.0a 6455 16.8a
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than two bacterial species was detected, up to ten species 
in one sample. Currently, reporting of PCR results differs 
from that for conventional culturing in that all target spe-
cies detected in the sample in DNA quantities above the 
cycle threshold cut-off for the test are reported whereas 
in culturing, samples with three or more species grow-
ing on the plate are discarded, the plate being considered 
contaminated [26]. Sporadic colonies of minor pathogens 
or common contaminants on a plate with growth of a 
major mastitis pathogen are commonly ignored [24]. The 
same interpretation system could be applied also in PCR 
diagnostics [31]. In general, PCR testing has proven to be 
a fast, sensitive and reliable test suitable for routine mas-
titis bacteriology [24, 28, 32]. An advantage of the PCR 
test is the comprehensive panel of pathogens, and uni-
form procedure and interpretation, in contrast to bacte-
riological culturing, where performance and procedures 
of laboratories may differ [33]. High costs of molecular 
methods such as PCR may still limit their use for mastitis 
diagnostics in many countries.
Our pathogen distributions (Table 2) can be compared 
with those from previous studies even though others 
used conventional culture methods. In the present study, 
the most common bacterial species in the samples with 
DNA of only one target species or group of species were 
CNS (43.3%), followed by S. aureus (21.1%). The propor-
tion of CNS agrees with previous findings in the Finnish 
national survey, where 49.6% of the isolates were CNS 
[16], but is much higher than in another Finnish study by 
Koivula et al. [17], who reported that CNS caused 18% of 
clinical and 24% of subclinical mastitis. In the study by 
Pitkälä et al. [16], the samples were taken from all quar-
ters of all cows in the herds and thus the findings for bac-
terial infection were mainly associated with subclinical 
mastitis or teat end colonization. Our high proportion 
of CNS may partly be explained by the sensitivity of the 
PCR assay as compared with conventional culturing [24]. 
The high average Ct value for samples with CNS, gener-
ally indicating little DNA in the samples, also supports 
this view (Table 2).
The most common bacteria found in the milk sam-
ples of cows with recorded treatment of clinical mastitis 
were CNS and S aureus, with equal shares. The amount 
of CNS detections in milk samples (in total) was double 
compared to that of S. aureus detections (Table 2), show-
ing that most S. aureus detections but only part of CNS 
detections lead to treatment of clinical mastitis. CNS are 
considered to be minor pathogens but are able to cause 
clinical mastitis, mostly mild [34]. It is possible that with 
changes in the dairy industry CNS currently cause more 
clinical mastitis than before, but another more likely 
explanation may be that herd staff are sensitive to react 
to mastitis with mild or transient clinical signs, aiming 
to keep bulk milk SCC low. Clinical mastitis is a broad 
term that includes all cases with any visible clinical sign, 
including mild changes in the milk appearance or con-
sistency [35]. The high proportion of CNS in our study 
was not surprising because they have become very com-
mon IMI- and mastitis-causing agents in Finland and 
many other countries [15, 36, 37].
In our study, the proportion of S. aureus (21%) was 
higher than in the Finnish national survey (10%) [16]. It 
was similar to the proportion reported for clinical masti-
tis in Sweden [38], but high compared with studies from 
other countries [12, 15, 39, 40]. The high proportion of 
S. aureus recorded here means that this pathogen contin-
ues to be extensively responsible for mastitis problems in 
Finnish dairy herds. The proportions of Str. uberis (9.0%), 
Str. dysgalactiae (7.9%) and E. coli (4.7%) were similar to 
the results of Koivula et al. [17]. It is difficult to compare 
our proportion of C. bovis (7.2%) with that for other stud-
ies, in particular with those on clinical mastitis, because 
C. bovis is seldom reported. In the national survey, its 
proportion was over 34%, but then all cows and quarters 
in the study herds were sampled [16]. In samples with 
two bacterial species with one dominant species the most 
common concomitant species detected were C. bovis, 
CNS, yeasts, and T. pyogenes/P. indolicus. All these spe-
cies are potential contaminants that originate from the 
teat end or barn environment, and their presence in milk 
samples is mostly of no clinical importance.
A clear difference between our results and those from 
other studies is the much higher proportion of environ-
mental pathogens in many other countries. In studies 
from the UK, Str. uberis were the species most commonly 
isolated, followed by Enterobacteriacae [12, 14]. In 
another countries, environmental streptococci were the 
most common finding in clinical mastitis [13, 39]. Str. 
agalactiae was rarely detected in this study (382 cows). 
These samples originated mainly from a few large herds: 
57% of the samples were from herds with more than 99 
cows and 27% from herds of 69–99 cows. Many samples 
came from the same cows: 22% of Str. agalactiae-positive 
cows had at least two positive samples (one to five posi-
tive samples) (data not shown). The herds with sampled 
cows were probably included in eradication programs. 
We conclude that proportions of mastitis-causing bacte-
rial species always differ among countries and herds due 
to different environmental and management factors [13, 
18, 41].
The Finnish cattle health monitoring system is mainly 
based on records of diagnoses and treatments made by 
veterinarians [42]. In contrast to the situation in many 
other countries, in Finland, as in all Nordic countries, 
antimicrobials are prescription-only medicines and 
strictly controlled by veterinarians. The current Finnish 
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legislation on medical treatment of animals emphasizes 
the importance of microbiological diagnosis before any 
antimicrobial treatment of dairy cattle. In most cases 
when herd staff identifies a cow with clinical mastitis they 
contact their veterinarian who visits the farm. In cases of 
subclinical and mild clinical mastitis, herd staff first take 
a milk sample and then contact their veterinarian. Such 
cases do not necessarily receive antimicrobial treatment. 
In our study, on average 35.7% of the cows in the study 
group and 6.2% of the control cows had a recorded mas-
titis treatment during lactation. The significant difference 
between the sampled study cows and the control cows 
was expected.
In Finland, based on the numbers of milk samples, 
total number of dairy cows and antimicrobial consump-
tion figures, it can be estimated that a milk sample for 
bacteriology is taken in a majority of mastitis cases [43]. 
We found that quarter milk samples were submitted to 
the laboratory on average for nearly 60% and, in the last 
study year, over 60% of the cows with a recorded treat-
ment during lactation. It must be pointed out that the 
recording completeness for veterinary-supervised cases 
of mastitis in Finland has not been 100%, but accord-
ing to a Nordic study only 56% (95% confidence interval 
48–64%) [23]. Consequently, treatment records may be 
missing from our data, although disease reporting for 
dairy cows probably has become more complete since 
2008 when the study of Wolff et al. [23] was carried out. 
Disease recordings are now done through the national 
herd health system Naseva [44] with which control of 
treatments has improved.
Control cows with a recorded treatment were either 
treated without taking a milk sample or the sample was 
taken but not analyzed in the laboratory of Valio Ltd. In 
Finland, veterinarians sometimes use triplate agars for 
rapid diagnosis of acute clinical mastitis and the results 
are generally not recorded [45]. It is still likely that mas-
titis cases diagnosed and sampled by farmers and treated 
via a veterinary prescription may remain unrecorded; this 
is supported by the low figure for treatments recorded 
with the specific code for notes of herd staff for treatment 
(data not shown). Many cows are repeatedly treated. The 
average number of treatments per cow was 1.3 and treat-
ments may further accumulate for some of the cows.
The number of cows with recorded treatments for 
subclinical or chronic mastitis during lactation was low, 
which complies with the Finnish guidelines for masti-
tis treatment, where it is generally advised to postpone 
treatment of subclinical mastitis during lactation until 
drying-off, and treatment of chronic mastitis is not 
recommended [46]. Another possibility is that these 
treatments, often given by herd staff after veterinary pre-
scription, are not reported. DCT was administered on 
average to 9.4% of the study cows and to 5.0% of control 
cows, and respectively 6.4 and 0.8% of the cows had been 
treated both during lactation and with DCT. Based on 
the consumption figures for intramammary products in 
Finland, approximately 22% of cows receive DCT [43]. 
Thus a considerable part of the treatment records for 
DCT are missing from our data. Figures for proportions 
of cows treated both during lactation and at drying-off 
were unexpectedly low. In general, DCT is recommended 
for cows that have had mastitis during lactation [46], but 
seemingly this advice is not followed on Finnish dairy 
farms.
Identification of the causal agent of IMI is important 
for mastitis management and treatment, but the routine 
is still rare in many countries and herds. For instance, in 
the Netherlands, only 34% of farmers submit milk sam-
ples for microbial analysis from cows with clinical mas-
titis and 22% from those with subclinical mastitis [10]. 
Prevention strategies in the herds should be pathogen-
specific because problems caused by different bacteria 
need different approaches [11]. Treatment of mastitis 
should be based on microbiological diagnosis to avoid 
inefficient or unnecessary use of antimicrobials [14, 47, 
48]. Even simple on-farm diagnostics, which only clas-
sifies mastitis-causing agents into Gram-negative and 
Gram-positive, has proven to be useful and reduced 
treatment costs [49, 50].
In the study group, mastitis was the reason for nearly 
half of the culled cows; in the control group the respec-
tive proportion was lower, as expected. Culling because 
of mastitis generally represents premature culling, which 
constitutes one-fifth of the costs of clinical mastitis in 
Finland [8]. The comparison of the shares of the patho-
gens in Tables 2 and 4 indicates that S. aureus was more 
common among culled cows than in the whole sample 
data. Thus, presence of S. aureus means increased risk 
of culling the cow. This may reflect the often poor out-
come for treatment of mastitis caused by S. aureus [51]. 
The shares of the rest five pathogens presented in Table 4 
were similar or lower among culled cows than in the 
whole dataset indicating that only S. aureus is a real risk 
factor for culling due to mastitis. However, more detailed 
studies on pathogen-specific diagnoses and treatment 
data using our large database will be carried out.
Conclusions
In Finland, quarter milk samples are routinely taken 
from cows with mastitis. Most are analyzed using a PCR-
test which has proven to be an applicable method also 
for large-scale use in bacterial diagnostics. In the pre-
sent study, microbiological diagnosis was unequivocal 
in the great majority of samples in which only one spe-
cies or two species with one dominating were detected. 
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The reporting of results with more than two species 
detected should be improved to make the interpretation 
easier. CNS and S. aureus were the most common spe-
cies detected in the milk samples whereas the propor-
tion of environmental pathogens was lower than in many 
other countries. S. aureus was also the most common 
pathogen among the culled cows, which emphasizes the 
importance of preventive measures. Mastitis treatments 
are probably often based on bacterial diagnosis, but the 
activity of dairy farmers to submit milk samples for bac-
terial analysis could be further increased. With patho-
gen-specific treatments, inefficient and unnecessary use 
of antimicrobials can be decreased, which also improves 
food safety.
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